Препараты Анемия

Главная | Astellas Pharma Russia

Asia Business Daily on Twitter: "Astellas Pharm...

Astellas Pharma: A Contrarian Investment (OTCMK...

FDA blocks Astellas’ Claudin cancer drug over m...

FDA Approves Astellas’ Non-hormonal Menopause T...

Astellas

Главная | Astellas Pharma Russia

Astellas Pharma Joins Record Bond Sales by Japa...

Pharmaceutical Technology

Home | Astellas Pharma Canada, Inc.

Astellas licenses 4DMT’s AAV vector for ophthal...

Astellas Pharma Projects :: Photos, videos, log...

Astellas Pharma EMEA celebrates its 10th annive...

Astellas Pharma - Global Web Site on Behance

Astellas Home page | Astellas Pharma Inc.

Astellas Pharma on LinkedIn: 医薬品の枠を超えた...

Атлас лекарственных растений - YouTube

Astellas Pharmaceuticals Establishes Open Innov...

China Formally Arrests Japanese Employee of Dru...

Japan's Astellas sees cancer drug fueling 29% p...

Astellas Pharma

Astellas Pharma Inc. (4503N.MX) stock price, ne...

Astellas introduces sustainable community initi...

Astellas' Prostate Cancer Drug Available In Jap...

US FDA approves Astellas Pharma pill for menopa...

Astellas Pharma US on LinkedIn: FDA Grants Prio...

Astellas, University of Tokyo extend partnershi...

Astellas Trains Sights On Iveric Bio In $5.9 Bi...

Astellas gets FDA priority review for gastric c...

Astellas Pharma to acquire Propella Therapeutic...

Astellas Home page | Astellas Pharma Inc.

Astellas Offloads 5 Legacy Products to Germany’...

FDA Grants Full Approval for Astellas Pharma's ...

Astellas Sues Over New Myrbetriq Patent to Reca...

About | Astellas Pharma Ltd